. . . . . . . . . "When we asked about the long-term treatment of BD, after having excluded from the analyses the 3 SGAs with a European indication for maintenance BD treatment (aripiprazole, olanzapine, and quetiapine), asenapine was considered either “highly appropriate” or “appropriate” by 44.6% of the respondents, while other off-label SGAs (clozapine, paliperidone, risperidone, ziprasidone) were mostly considered inappro- priate for maintenance bipolar treatment" . . . . . . "Adults" . . "2021-08-17T13:35:51.063600"^^ . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "kYj+cgZGV/ADRMOPicQhPuGaPOBRQzx/40hrrPzYCmGFXxjw6XhltP1OA2m6zIgknurH4c3TDksrBEuSZ1QPaRmvGDAQCARvySmpxlzwNhCPIwc/RwbK9oft8lXooD+ZQcqBUJ2lE91ulLIwL1YjirBdKSmX6Oj0WDitzFzgAE8=" . . "2021-08-17T13:35:51.063600"^^ . . .